series-a
Stage
2
Investors
About
NRG Therapeutics is a drug discovery company targeting mitochondrial dysfunction to slow or prevent the progression of neurodegenerative diseases.
Explore NRG Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.